News
      Updates

The latest news from Holyoke Medical Center
News Updates

Holyoke Medical Center Receives Full Accreditation as National Breast Cancer Center 

HMC Breast Cancer Center Among State's Best

The Holyoke Medical Center Oncology Department is pleased to announce that, once again, it has been granted a three-year/full accreditation designation by the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons. 

"It is an honor and privilege to be accredited by the NAPBC," said Oncology Nurse and Certified Patient Navigator Jolene Lambert, R.N. "Having these credentials reflects the comprehensiveness of the care we provide. We work well with all the different providers, and have the necessary support to help breast cancer patients from the time they're diagnosed, through survivorship," she said.

Oncology and Women's Center staff underwent the rigorous evaluation process this Spring. HMC passed with flying colors, demonstrating proficiency and excellence in the areas of leadership, clinical management, research, community outreach, professional education and quality improvement, said Medical Director Dr. Zubeena Mateen, who directs HMC's Breast Cancer Program.

"We have a state-of-the-art facility, with board-certified physicians and oncologists. We offer everything - high-resolution digital mammography, MRI guided biopsies, stereotactic core needle biopsies, surgeries, individualized treatment plans and extensive follow-up," said Mateen.

Accreditation by the NAPBC is only given to those centers that have voluntarily committed to provide the highest level of quality breast care and that undergo a rigorous evaluation process and review of their performance. The standards include proficiency in the areas of: center leadership, clinical management, research, community outreach, professional education, and quality improvement.  A breast center that achieves NAPBC accreditation has demonstrated a firm commitment to offer its patients every significant advantage in their battle against breast disease.

NAPBC1

view all HMC News Stories >>